UCL Business
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
90 Tottenham Court Rd, London, Greater L...Phone Number
+44 2076799000Website
www.uclb.comRevenue
$9.4 MillionIndustry
About UCL Business
UCL Business Org Chart
Is UCL Business your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
UCL Business, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when UCL Business launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on UCL Business recently announced quarterly report
Click to see if UCL Business had a recent Job posting/layoffs
Funding: Get notified immidiatlly once UCL Business has new funding data
Check out if UCL Business is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at UCL Business
Website visits: Recent activity has been detected on your website
Check if UCL Business has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at UCL Business
Find more new buyers
Compare Similar Companies to UCL Business
Compare insights from companies similar to UCL Business, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
UCL Business is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
UCL Business is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about UCL Business.
UCL Business Tech Stack
A closer look at the technologies used by UCL Business
Most Recent Scoops
UCL Business News & Media
Qualigen Therapeutics Secures Option to Negotiate License for G-Quadruplex Anti-Cancer Technology from UCL
CARLSBAD, Calif., March 01, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and viral diseases, announced today it has entered into a Material Evaluation and Option Agreement with the University College London (UCL) to advance development of and potentially expand toward future commercial uses of Qualigen's leading anticancer drug candidate AS1411-GNP, also known as ALAN (Aptamer-LinAutolus Therapeutics announces publication of new AUTO6 Phase 1 data in childhood neuroblastoma in Science Translational Medicine
- Findings from the Phase 1 study provide evidence that AUTO6 induces clinical activity in this solid tumor setting without inducing on-target off-tumor toxicityUCLB and Apollo Therapeutics secure first out-licensing deal to Deerfield, a leading U.S. healthcare investment firm
LONDON & NEW YORK--(BUSINESS WIRE)--UCL Business (UCLB) and Apollo Therapeutics (Apollo), a pioneering collaboration between three global pharmaceutical companies and three UK university technology transfer offices, along with Deerfield Management Company, have completed the licensing of the first Apollo-supported project, a novel gene therapy programme developed at University College London (UCL). Through this deal, the technology will be further developed in partnership with Deerfield, bui
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding UCL Business
UCLB is the commercialisation company of University College London, dedicated to bringing world-leading technologies and innovations to market. They collaborate with UCL's esteemed academics and hospitals to protect and commercialise pioneering ideas that address significant global challenges. UCLB offers services such as research commercialisation... Read More